| Literature DB >> 27559373 |
Jarosław Lewkowski1, Maria Rodriguez Moya1, Anna Wrona-Piotrowicz1, Janusz Zakrzewski1, Renata Kontek2, Gabriela Gajek2.
Abstract
A large series of variously substituted amino(pyren-1-yl)methylphosphonic acid derivatives was synthesized using a modified aza-Pudovik reaction in 20-97% yields. The fluorescence properties of the obtained compounds were investigated revealing that N-alkylamino(pyren-1-yl)methylphosphonic derivatives are stronger emissive compounds than the corresponding N-aryl derivatives. N-Benzylamino(pyren-1-yl)methylphosphonic acid displayed strong fluorescence (ΦF = 0.68) in phosphate-buffered saline (PBS). The influence of a series of derivatives on two colon cancer cell lines HT29 and HCT116 was also investigated. The most promising results were obtained for N-(4-methoxyphenyl)amino(pyren-1-yl)methylphosphonate, which was found to be cytotoxic for the HCT116 cancer cell line (IC50 = 20.8 μM), simultaneously showing weak toxicity towards normal lymphocytes (IC50 = 230.8 µM).Entities:
Keywords: MTT test; aminophosphonic derivatives; cytotoxicity; fluorescence properties; pyrene-1-carboxaldehyde
Year: 2016 PMID: 27559373 PMCID: PMC4979872 DOI: 10.3762/bjoc.12.117
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.883
Scheme 1Synthesis of aminophosphonates 3Aa–j, 3Ba–e, 3Ca–d, 3Cg, aminophosphonic acids 4a, 4c and hydroxyphosphonate 5A.
Absorption and emission maxima and fluorescence quantum yields (ΦF) for the synthesized compounds in chloroform solution (c = 1 μM).
| Compd. | Absorption | Emissiona | ΦFb |
| 304, 317, 330, 347 | 378, 388, 399 | 0.06 | |
| 304, 316, 331, 347 | 378, 388, 398 | 0.06 | |
| 304, 316, 331, 348 | 378, 389, 399 | 0.06 | |
| 304, 317, 331, 348 | 382, 397, 424, 444 | <0.01 | |
| 304, 318, 330, 348 | 382, 397, 443 | <0.01 | |
| 305, 318, 332, 349 | 382, 397, 455 | <0.01 | |
| 304, 317, 331, 348 | 380, 395, 485 | <0.01 | |
| 304, 316, 330, 448 | 380, 395, 484 | <0.01 | |
| 304, 317, 330, 448 | 380, 396, 485 | <0.01 | |
| 304, 317, 331, 348 | 380, 398, | <0.01 | |
| 304, 317, 330, 348 | 380, 398 | <0.01 | |
| 304, 317, 331, 348 | 381, 398 | <0.01 | |
| 303, 316, 330, 347 | 378, 390, 398 | 0.10 | |
| 303, 316, 330, 346 | 377, 389, 397 | 0.10 | |
| 303, 317, 330, 347 | 378, 390, 398 | 0.09 | |
| 316, 330, 347 | 378, 390, 398 | 0.05 | |
| 303, 316, 330, 347 | 380, 395 | <0.01 | |
| 318, 331, 347 | 378, 389, 397 | 0.11 | |
| 303, 316, 329, 345 | 378, 397, 419 | 0.68 | |
| 317, 330, 347 | 377, 388, 396 | 0.13 | |
aExcitation was set at the maximum of the lowest energy absorption band. bMeasured for aerated solutions. Quenching by dissolved dioxygen was not observed. cMeasured for an aqueous 0.01 PBS (phosphate-buffered saline) solution (pH 7.4)
Figure 1Normalized electronic absorption and emission spectra of 3Aj and pyrene in chloroform (c = 1 μM).
Figure 2Emission spectra of compound 3Aj in various solvents. The spectra are normalized at ≈378 nm (pyrene band I).
IC50 values on studied compounds.
| Compound | R1 | lymphocytes | HT29 | HCT116 |
| CH2Ph | IC50 = 89.2 ± 2.9 µM | IC50 = 29.2 ± 3.84 µM | IC50 = 29 ± 2.37 µM | |
| Ph | IC50 = 334.2 ± 2.59 µM | IC50 = 105.8 ± 3.37 µM | IC50 = 70.8 ± 2.99 µM | |
| 4-C6H4-CH3 | IC50 = 17.5 ± 4.15 µM | IC50 = 15.8 ± 3.44 µM | IC50 = 15.9 ± 4.85 µM | |
| 4-C6H4-OCH3 | IC50 = 230.8 ± 3.43 µM | IC50 = 24.2 ± 5.12 µM | IC50 = 20.8 ± 3.48 µM | |
| 3-C6H4-CH3 | IC50 = 75.8 ± 4.02 µM | IC50 = 57.5 ± 5.19 µM | IC50 = 20.21 ± 5.63 µM | |
| – | IC50 = 135.8 ± 1.73 µM | IC50 = 25.8 ± 4.99 µM | IC50 = 40.4 ± 4.53 µM | |
Figure 3IC50 values of studied compounds.